All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 10 of 206 pages ‹ First  < 8 9 10 11 12 >  Last ›

HSL18921
Grogan K
Worldwide drug sales to hit $880 billion in 2011
Pharma Times 2010 Oct 7
http://www.pharmatimes.com/Article/10-10-07/Worldwide_drug_sales_to_hit_880_billion_in_2011.aspx

HSL18744
Silverman E
Want To Milk A Cash Cow? Try Pediatric Exclusivity
Pharmalot 2010 Oct 7
http://www.pharmalot.com/2010/10/want-to-milk-a-cash-cow-try-pediatric-exclusivity/

HSL18745
Taylor L
Pharma 'conflicts' slammed in health fraud report
Pharma Times 2010 Oct 7
http://www.pharmatimes.com/Article/10-10-07/Pharma_“conflicts”_slammed_in_health_fraud_report.aspx

HSL18867
Arie S
Most OECD countries could save money by improving clinical guidelines and negotiating better drug prices
BMJ 2010 Oct 7;341:
http://www.bmj.com/content/341/bmj.c5552

HSL19667
Stuebe A
Nestle, AAP Partnership half-baked
Breastfeeding Medicine 2010 Oct 7
http://bfmed.wordpress.com/2010/10/07/nestle-aap-partnership-half-baked/

HSL18832
Edwards J
Drug Companies Urge Supreme Court to Let Them Stay Silent on Side Effects
BNet 2010 Oct 6
http://www.bnet.com/blog/drug-business/drug-companies-urge-supreme-court-to-let-them-stay-silent-on-side-effects/6002

HSL18868
Garattini S, Bertele V,
Rosiglitazone and the need for a new drug safety agency
BMJ 2010 Oct 6;341:
http://www.bmj.com/content/341/bmj.c5506

HSL18931
Harvey urges GMiA data
Pharmacy Daily 2010 Oct 6

HSL18737
Juredini J
DSM-5 — dodgy decisions and disorders
MJA InSight 2010 Oct 5;
http://www.mjainsight.com.au/view?post=dr-jon-jureidini-dsm-5---dodgy-decisions-and-disorders&post_id=708&cat=comment

HSL18850
Teichert E
Big Pharma behaving badly: A timeline of settlements
Fierce Pharma 2010 Oct 5
http://www.fiercepharma.com/special-reports/big-pharma-behaving-badly-timeline-settlements

HSL18869
Watson R
Drug companies must provide 'unbiased information' to patients, say MEPs
BMJ 2010 Oct 5;341:
http://www.bmj.com/content/341/bmj.c5511

HSL18881
Rothfeld M
Drug Firms Face Bribery Probe
The Wall Street Journal 2010 Oct 5
http://online.wsj.com/article_email/SB10001424052748704847104575532091781199092-lMyQjAxMTAwMDAwNTEwNDUyWj.html

HSL18899
Wokasch M
Why Some Pharmaceutical Sales Managers Hate to Manage Professional Representatives?
Pharma Reform 2010 Oct 5
http://www.pharmareform.com/2010/10/05/why-some-pharmaceutical-sales-managers-hate-to-manage-professional-representatives

HSL18733
Silverman E
Living In Unethical Times: Carl Elliott Explains
Pharmalot 2010 Oct 4
http://www.pharmalot.com/2010/10/living-in-unethical-times-carl-elliott-explains/

HSL18736
Vass B
Painkiller adverts misleading, panel rules
The NZ Herald 2010 Oct 4
http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10678013

HSL18907
Arnold M
AstraZeneca site offers docs live chat with reps
Medical Marketing & Media 2010 Oct 4
http://www.mmm-online.com/astrazeneca-site-offers-docs-live-chat-with-reps/article/180347/

HSL18734
Wilson D
Side Effects May Include Lawsuits
The New York Times 2010 Oct 3
http://www.nytimes.com/2010/10/03/business/03psych.html?_r=1

HSL18735
Cooper D
Glaxosmithkline cuts Far East prices to boost share of market
Telegraph.co.uk 2010 Oct 3
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/8038687/Glaxosmithkline-cuts-Far-East-prices-to-boost-share-of-market.html

HSL18726
Jack A
US research funder licenses HIV patent
The Finanical Times 2010 Oct 1
http://www.ft.com/cms/s/0/7ddb559e-ccaa-11df-a1eb-00144feab49a.html

HSL18727
Silverman E
Novartis Whistleblower Speaks: ‘We Wasted Money’
Pharmalot 2010 Oct 1
http://www.pharmalot.com/2010/10/a-novartis-whistleblower-speaks-we-wasted-money/

HSL18728
Taylor L
MEPs reject Euro Commission plan for pharma info
Pharma Times 2010 Oct 1
http://www.pharmatimes.com/Article/10-10-01/MEPs_reject_Euro_Commission_plan_for_pharma_info.aspx

HSL18910
Welsh J
Dr. James’s Fever Powder, circa 1746
The Scientist 2010 Oct 1
http://www.the-scientist.com/article/display/57714

HSL18717
Appelbaum PS, Gold A.
Psychiatrists' relationships with industry: the principal-agent problem.
Harv Rev Psychiatry 2010 Oct;18:(5):255-65
http://informahealthcare.com/doi/abs/10.3109/10673229.2010.507038

HSL18738
Handelsman DJ
Testosterone and male ageing: spinning the wheels
MJA 2010 Oct;193:(7):379-380
http://www.mja.com.au/public/issues/193_07_041010/han10827_fm.html

HSL18872
Sillup GP, Trombetta B, Klimberg R.
The 2002 PhRMA Code and Pharmaceutical Marketing: Did Anybody Bother to Ask the Reps?
Health Mark Q 2010 Oct;27:(4):388-404
http://www.ncbi.nlm.nih.gov/pubmed/21058100

HSL18935
AIM, HAI Europe, ISDB, MiEF
Pharmaceutical companies 'informing' the public: one step closer to legalising reminder advertising for prescription drugs?
Joint Briefing document 2010 Oct

HSL18951
Hoey J
Should medical journals carry pharmaceutical advertising?: No
Can Fam Physician. 2010 Oct;56:(10):979-81
http://www.cfp.ca/cgi/content/full/56/10/979

HSL18952
Dehaas D
Should medical journals carry pharmaceutical advertising?: Yes
Can Fam Physician 2010 Oct;56:(10):978-80
http://www.cfp.ca/cgi/content/full/56/10/978

HSL19170
Big stick won’t work with industry sponsorship
MJA InSight 2010 Oct;
http://www.mjainsight.com.au/view?post=big-stick-won%25e2%2580% 2599t-work-with-industry-sponsorship&post_id=1112&cat=issue-15-11-october-2010

HSL19151
Mali SN, Dudhgaonkar S, Bachewar NP
Evaluation of rationality of promotional drug literature using World Health Organization guidelines
Indian J Pharmacol 2010 Oct;42:(5):267-72
http://www.ijp-online.com/article.asp?issn=0253-7613;year=2010;volume=42;issue=5;spage=267;epage=272;aulast=Mali

HSL18729
Silverman E
Novartis Pays $422M For Off-Label Marketing
Pharmalot 2010 Sep 30
http://www.pharmalot.com/2010/09/novartis-pays-422m-for-off-label-marketing-charges/

HSL18765
Sharma DC
Egg on the academies' faces over eggplant
India Today 2010 Sep 30
http://indiatoday.intoday.in/site/Story/114526/centre-to-invite-all-groups-for-dialogue-on-kashmir.html?complete=1

HSL18833
Edwards J
Novartis Paid Kickbacks to Doc Lecturers Even If They Couldn't Speak English
BNet 2010 Sep 30
http://www.bnet.com/blog/drug-business/novartis-paid-kickbacks-to-doc-lecturers-even-if-they-couldn-8217t-speak-english/5942

HSL18958
Moynihan R.
Merging of marketing and medical science: female sexual dysfunction.
BMJ 2010 Sep 30;341:c5050:
http://www.bmj.com/content/341/bmj.c5050.long

HSL19141
Angell M
FDA: This Agency Can Be Dangerous
The New York Review of Books 2010 Sep 30
http://www.nybooks.com/articles/archives/2010/sep/30/agency-can-be-dangerous/

HSL18730
Silverman E
The Shocking Truth About Free Lunches And Pens
Pharmalot 2010 Sep 29
http://www.pharmalot.com/2010/09/the-shocking-truth-about-free-lunches-and-pens/

HSL19200
Mckee S
Pfizer slapped with price-fixing fine in Indonesia
Pharma Times 2010 Sep 29
http://www.pharmatimes.com/Article/10-09-29/Pfizer_slapped_with_price-fixing_fine_in_Indonesia.aspx

HSL18956
Hunt P, Khosla R.
Are drug companies living up to their human rights responsibilities? The perspective of the former United nations special rapporteur (2002-2008).
PLoS Med 2010 Sep 28;7:(9):
http://dx.plos.org/10.1371/journal.pmed.1000330

HSL18957
Gruskin S, Raad Z
Are drug companies living up to their human rights responsibilities? Moving toward assessment.
PLoS Med. 2010 Sep 28;7:(9):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000310

HSL18973
Pfizer, Dexa fined for price fixing
The Jakarta Post 2010 Sep 28
http://www.thejakartapost.com/news/2010/09/28/pfizer-dexa-fined-price-fixing.html

HSL18985
Hendrick B
FDA: Popular Mouthwashes Make False Claims
WebMD 2010 Sep 28
http://www.webmd.com/oral-health/news/20100928/fda-popular-mouthwashes-make-false-claims

HSL19267
Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities
PLoS Med 2010 Sep 28;
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371% 2Fjournal.pmed.1000344

HSL18724
Silverman E
Pfizer Attacks Journal For Undisclosed Conflicts
Pharmalot 2010 Sep 27
http://www.pharmalot.com/2010/09/pfizer-attacks-journal-for-undisclosed-conflicts/

HSL18725
Elliott C, Fugh-Berman A, Barbour V
Concerns re: Incomplete 'Competing Interests' Disclosure
PLoS Med 2010 Sep 27;
http://www.plosmedicine.org/annotation/listThread.action?inReplyTo=info:doi/10.1371/annotation/9615f3f1-520f-43cd-a825-8afcab3c26d4&root=info:doi/10.1371/annotation/9615f3f1-520f-43cd-a825-8afcab3c26d4

HSL18731
Gordon S
Pediatricians Want to Restrict Ads for Tobacco, Booze, Viagra
Yahoo News 2010 Sep 27
http://news.yahoo.com/s/hsn/20100928/hl_hsn/pediatricianswanttorestrictadsfortobaccoboozeviagra

HSL18834
Edwards J
Blue Light Special: Viagra -- and Its Risks -- Now Available Without Rx in U.K. Supermarkets
BNet 2010 Sep 27
http://www.bnet.com/blog/drug-business/blue-light-special-viagra-8212-and-its-risks-8212-now-available-without-rx-in-uk-supermarkets/5875

HSL19662
Abshear D
MD$ on the Take: My Career-Ending Expose
HenryMakow.com 2010 Sep 27
http://www.henrymakow.com/i_was_a_corporate_whistle_blow.html

HSL18705
Silverman E
Avandia: Lessons Learned & Unanswered Questions
Pharmalot 2010 Sep 24
http://www.pharmalot.com/2010/09/avandia-lessons-learned-unanswered-questions/

HSL18706
Herper M
The End Of Drug Withdrawals?
Forbes Blog 2010 Sep 24
http://blogs.forbes.com/matthewherper/2010/09/24/the-end-of-drug-withdrawals/

HSL18770
Harrington C, Khanfar NM, Bond DR, Vila I
Utilising the medical literature for market research: Finding new approaches to marketing substance abuse treatment clinics
J Med Market 2010 Sep 24;10:344-351
http://www.palgrave-journals.com/jmm/journal/v10/n4/abs/jmm201025a.html

HSL18704
Grogan K
European Parliament endorses drug monitoring rules
Pharma Times 2010 Sep 23
http://www.pharmatimes.com/Article/10-09-23/European_Parliament_endorses_drug_monitoring_rules.aspx

HSL18708
Breggin P
Making a Market in Antipsychotic Drugs: An Ironic Tragedy
The Huffington Post 2010 Sep 23
http://www.huffingtonpost.com/dr-peter-breggin/making-a-market-in-antips_b_720861.html

HSL18699
Kavilanz P
FDA: Motrin maker played us over recall
CNN Money 2010 Sep 22
http://money.cnn.com/2010/09/21/news/companies/Motrin_recall_fda_mcneil_exchange/index.htm

HSL18707
Cloud J
ADHD: A Global Epidemic or Just a Bunch of Fidgety Kids?
Time Healthland 2010 Sep 22
http://healthland.time.com/2010/09/22/adhd-a-global-epidemic-or-just-a-bunch-of-fidgety-kids/

HSL18718
Kuehn BM.
Inconsistent results, inaccurate claims plague direct-to-consumer gene tests.
JAMA 2010 Sep 22;304:(12):1313-5
http://jama.ama-assn.org/cgi/content/full/304/12/1313

HSL18986
Stafford N
Proportion of spending on brand name drugs continues to rise in Germany
BMJ 2010 Sep 22;341:
http://www.bmj.com/content/341/bmj.c5185.extract

HSL19268
Bastian H, Glasziou P, Chalmers I
Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
PLoS Med 2010 Sep 21;
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000326

HSL18696
Silverman E
Feds Intervene In Pfizer Suit Over Targeting Blacks
Pharmalot 2010 Sep 21
http://www.pharmalot.com/2010/09/feds-intervene-in-wyeth-suit-over-targeting-blacks/

HSL18698
Jack A
Pharmaceuticals: Perils for pill pushers
The Finanical Times 2010 Sep 21
http://www.ft.com/cms/s/5cc9d62e-c5b5-11df-ab48-00144feab49a,Authorised=false.html?_i_location=http://www.ft.com/cms/s/0/5cc9d62e-c5b5-11df-ab48-00144feab49a.html&_i_referer=

HSL18700
Wilson D
U.S. Joins Pfizer Suit Over Drug's Marketing
The New York Times 2010 Sep 21
http://www.nytimes.com/2010/09/22/business/22drug.html?_r=1

HSL18719
Greene JA
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine.
J Hist Med Allied Sci 2010 Sept 21;
http://jhmas.oxfordjournals.org/content/early/2010/09/21/jhmas.jrq049.long

HSL18701
Silverman E
A Senate Investigator Looks Back: Thacker Speaks
Pharmalot 2010 Sep 20
http://www.pharmalot.com/2010/09/a-senate-investigator-looks-back-thacker-speaks/

HSL18703
Taylor L
Drugmakers protest new Greek prices
Pharma Times 2010 Sep 20
http://www.pharmatimes.com/Article/10-09-20/Drugmakers_protest_new_Greek_prices.aspx

HSL18987
Mudur G
Industry lobbying and trade pacts threaten India’s role as major generics supplier
BMJ 2010 Sep 20;341:
http://www.bmj.com/content/341/bmj.c5135.extract

HSL18702
Newman M
Bitter pills for drug companies
BMJ 2010 Sep 17;341:
http://www.bmj.com/content/341/bmj.c5095.extract

HSL18711
Annes JP, Giovanni MA, Murray MF.
Risks of presymptomatic direct-to-consumer genetic testing.
N Engl J Med 2010 Sep 16;363:(12):1100-1
http://www.nejm.org/doi/full/10.1056/NEJMp1006029

HSL18694
Edwards J
$1,000 a Pop: How Forest Labs Bribed Doctors to Prescribe Antidepressants to Kids
BNet 2010 Sep 15
http://www.bnet.com/blog/drug-business/1000-a-pop-how-forest-labs-bribed-doctors-to-prescribe-antidepressants-to-kids/5753

HSL18713
Hamrell MR.
Raising Suspicions with the Food and Drug Administration: Detecting Misconduct.
Sci Eng Ethics 2010 Sep 15;
http://www.springerlink.com/content/xw4576h31m838186/

HSL18714
Sah S, Loewenstein G.
Effect of reminders of personal sacrifice and suggested rationalizations on residents' self-reported willingness to accept gifts: a randomized trial.
JAMA 2010 Sep 15;304:(11):1204-11
http://jama.ama-assn.org/cgi/content/full/304/11/1204

HSL18837
Arnold M
Headliner: Grassley's Ghostwriter Exits Hill
Medical Marketing & Media 2010 Sep 15
http://www.mmm-online.com/headliner-grassleys-ghostwriter-exits-hill/article/180052/

HSL18905
Arnold M
Patient Marketing Report: Thinking Past the Pill
Medical Marketing & Media 2010 Sep 15
http://www.mmm-online.com/patient-marketing-report-thinking-past-the-pill/article/180045/

HSL19181
McQuillen W
Forest Unit Pleads Guilty to Marketing Thyroid Drug, Will Pay $313 Million
Bloomberg Businessweek 2010 Sep 15
http://www.bloomberg.com/news/2010-09-15/forest-unit-agrees-to-plead-guilty-pay-313-million-in-levothroid-cases.html

HSL18693
Wilson A, Robertson J, McElduff P, Jones A, Henry D
Does It Matter Who Writes Medical News Stories?
PLoS Med 2010 Sep 14;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000323

HSL18697
Kowalczyk L
For physicians, another option on education
The Boston Globe 2010 Sep 14
http://www.boston.com/news/health/articles/2010/09/14/doctor_looks_to_cut_drug_industrys_sway_on_medicine/

HSL19252
Iskowitz M
New med-ed firm says no to industry funding
Medical Marketing & Media 2010 Sep 14
http://www.mmm-online.com/new-med-ed-firm-says-no-to-industry-funding/article/178875/

HSL18911
Chimonas S, Frosch Z, Rothman DJ
From Disclosure to Transparency: The Use of Company Payment Data
Arch Intern Med. 2010 Sep 13;
http://archinte.ama-assn.org/cgi/content/abstract/archinternmed.2010.341v1

HSL19276
O'Reilly KB
Drugmakers hold too much influence over doctors' decisions, public says
Americal Medical News 2010 Sep 13
http://www.ama-assn.org/amednews/2010/09/13/prsc0913.htm

HSL18695
Elliott C
The Secret Lives of Big Pharma's 'Thought Leaders'
The Chronicle of Higher Education 2010 Sep 12
http://chronicle.com/article/The-Secret-Lives-of-Big/124335/

HSL19182
Linder-Ganz R
Gehrig's patients demand Teva reveal Copaxone test results
Haaretz.com 2010 Sep 12
http://www.haaretz.com/print-edition/business/gehrig-s-patients-demand-teva-reveal-copaxone-test-results-1.313300

HSL18649
Feeley J
Allergan Directors Are Sued Over Marketing of Botox
Bloomberg.com 2010 Sep 8
http://www.bloomberg.com/news/2010-09-07/allergan-directors-are-sued-by-shareholders-over-marketing-of-botox-drug.html

HSL18669
Romualdez AG
Finger-pointing on ethics
Malaya 2010 Sep 8
http://www.malaya.com.ph/09082010/edromuald.html

HSL18671
Iskowitz M
Cephalon videos seek to bolster physician-patient dialogue
Medical Marketing & Media 2010 Sep 8
http://www.mmm-online.com/cephalon-videos-seek-to-bolster-physician-patient-dialogue/article/178482/

HSL18672
Staton T
Study details Wyeth ghostwriting on Prempro
Fierce Pharma 2010 Sep 8
http://www.fiercepharma.com/story/study-details-wyeth-ghostwriting-prempro/2010-09-08

HSL18650
Fugh-Berman AJ
The Haunting of Medical Journals: How Ghostwriting Sold 'HRT'
PLoS Med 2010 Sep 7;7:(9):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000335

HSL18652
Silverman E
Non-Profits And Industry Money: Who Gets What
Pharmalot 2010 Sep 7
http://www.pharmalot.com/2010/09/non-profits-and-industry-money-who-gets-what/

HSL18653
Silverman E
'No-See' Docs Will Talk To Reps At CME Meetings
Pharmalot 2010 Sep 7
http://www.pharmalot.com/2010/09/no-see-docs-will-talk-to-reps-at-cme-meetings/

HSL18660
Goozner M
Drug Marketing - A Form of Malpractice
GoozNews 2010 Sep 7
http://www.gooznews.com/node/3426

HSL18670
Taylor L
Greece cuts prices of over 4,000 drugs by 20%
PharmaTimes 2010 Sep 7
http://www.pharmatimes.com/Article/10-09-07/Greece_cuts_prices_of_over_4_000_drugs_by_20.aspx

HSL18640
Shankar R
Panel anguished over unethical practices of pharma cos to evade price control
PharmaBiz.com 2010 Sep 6
http://news.indiamart.com/story/parliamentary-panel-unhappy-over-corrupt-practices-pharma-firms-89451.html

HSL18644
Cohen D
Rosiglitazone: what went wrong?
BMJ 2010 Sep 6;341:
http://www.bmj.com/content/341/bmj.c4848.full

HSL18645
Godlee F
Are we at risk of being at risk?
BMJ 2010 Sep 6;341:
http://www.bmj.com/content/341/bmj.c4766.full

HSL18651
Lehman R, Yudkin JS, Krumholz H, Hines HH
Licensing drugs for diabetes
BMJ 2010 Sep 6
http://www.bmj.com/content/341/bmj.c4805

HSL18657
Poses RM
At the End of Summer, Everybody, Well, Nearly Everybody (Allergan, CVS Caremark, Stryker, WellStar) Settles
Health Care Renewal Blog 2010 Sep 6
http://hcrenewal.blogspot.com/2010/09/at-end-of-summer-everybody-well-nearly.html

HSL18641
Relação entre médicos e IF: 'é possível fazer melhor!'
Jornal Médico de Família 2010 Sep 3
http://www.jmfamilia.com/index.php?option=com_content&task=view&id=1191&Itemid=27

HSL18675
Hopkins Tanne J
US blog questions drug company funding of continuing education for journalists
BMJ 2010 Sep 3;341:
http://www.bmj.com/content/341/bmj.c4857.extract

HSL18680
Moynihan R
A health check for the business of medicine
ABC News 2010 Sep 3
http://www.abc.net.au/unleashed/stories/s3001738.htm

HSL18643
Silverman E
American Heart Association, Avandia & Ghostwriting
Pharmalot 2010 Sep 2
http://www.pharmalot.com/2010/09/american-heart-association-avandia-ghostwriting/

HSL18646
Larkin C
Allergan Will Pay Fine, Plead Guilty to Misdemeanor
Bloomberg.com 2010 Sep 2
http://www.bloomberg.com/news/2010-09-01/allergan-will-pay-600-million-plead-guilty-to-misdemeanor-in-botox-probe.html

HSL18655
Mack J
'Reasonable' $600 MILLION Fine for Misbranding BOTOX: I Guess Allergan's Suit Against FDA Paid Off!
Pharma Marketing Blog 2010 Sep 2
http://pharmamkting.blogspot.com/2010/09/reasonable-600-fine-for-misbranding.html

HSL18676
Iskowitz M
Meetings offer reps a shot at 'no-see' docs: survey
Medical Marketing & Media 2010 Sep 2
http://www.mmm-online.com/meetings-offer-reps-a-shot-at-no-see-docs-survey/article/178163/

Page 10 of 206 pages ‹ First  < 8 9 10 11 12 >  Last ›